Go back to News
NEWS
Gómez-Acebo & Pombo appoints two new partners and four of counsels
22 December, 2022
Yesterday, 21 December, Gómez-Acebo & Pombo held its Annual General Meeting and appointed two new partners and four of counsels. As a result, the Firm will have 54 equity partners by 2023.
These new appointments are a reflection of the Firm’s commitment to internal talent and ambitious, high-profile careers.
Paula Zarzalejos, from the Banking team, specialises in corporate finance and debt refinancing. Josep Ortiz, from the Public and Regulatory team, has developed his career between the Barcelona and Valencia offices and specialises in administrative law, public procurement and urban planning.
In addition, the Firm has promoted four of counsel, who will also strengthen the different practice areas: Lourdes Escassi, from the labour team, Eduardo Orteu, from the public and regulatory team, both from the Madrid office; and Luisa Carrilho da Graça, from the commercial team and Pedro Vilarinho Pires, competition team from the Lisbon office.
Read news in El Confidencial.
Read news in Expansión.
Read news in Cinco Días.
These new appointments are a reflection of the Firm’s commitment to internal talent and ambitious, high-profile careers.
Paula Zarzalejos, from the Banking team, specialises in corporate finance and debt refinancing. Josep Ortiz, from the Public and Regulatory team, has developed his career between the Barcelona and Valencia offices and specialises in administrative law, public procurement and urban planning.
In addition, the Firm has promoted four of counsel, who will also strengthen the different practice areas: Lourdes Escassi, from the labour team, Eduardo Orteu, from the public and regulatory team, both from the Madrid office; and Luisa Carrilho da Graça, from the commercial team and Pedro Vilarinho Pires, competition team from the Lisbon office.
Read news in El Confidencial.
Read news in Expansión.
Read news in Cinco Días.
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
¡NEW! 
PUBLICATION
¡NEW!
Pharma & Healthcare No. 49
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
¡NEW! 
PUBLICATION
5 days ago
Royal Decree 415/2026: key aspects of the new health technology assessment system
Royal Decree 415/2026 establishes a unified framework for the assessment of health technologies in Spain, distinguishing between the technical assessment and the administrative decision regarding funding, pricing or inclusion in the service catalogue, and incorporating the requirements of Regulation (EU) 2021/2282. The aspect that raises the most legal questions in this new piece of legislation is the connection between the assessment regulated by the Royal Decree and the procedures for funding, pricing, and inclusion in the service catalogue.
5 days ago
PUBLICATION
15 Jun, 2026
Conclusions on the abuse of temporary public sector employment: finding a balance between domestic laws and EU law
15 Jun, 2026
PUBLICATION
09 Jun, 2026
Partial limitation defences that may be raised in relation to the limitation period within a cartel (Supreme Court Judgment no. 681/2026 of 6 May)
A flawed judgment on a problem that has remained unresolved to date in the truck cartel. The issue is not whether the liability-in-solidum regime applies, but whether co-liable parties can raise personal defences.
09 Jun, 2026
PUBLICATION
09 Jun, 2026
The “serious risk” of financial assistance (Supreme Court (First Chamber) Judgment of 5 May 2026)
This paper critically analyses the Supreme Court ruling of 5May 2026, which applies the prohibition on financial assistance to a case involving the sale of treasury shares with deferred payment to the shareholders of the assisting company.
09 Jun, 2026
PUBLICATION
04 Jun, 2026
Unanimous shareholders' agreements and dividends in specie
The Supreme Court and the Madrid Provincial Court, following established legal doctrine, have reiterated that a party to a unanimous shareholders’ agreement acts in bad faith if he or she challenges a company resolution passed in compliance with said shareholders’ agreement. In this case, the shareholders’ agreement provided for the possibility of paying dividends in kind, and the contested resolution — which was passed by a majority at the shareholders’ meeting — transferred certain real estate properties to one of the shareholders (with his consent) in payment of the dividend due to him.
04 Jun, 2026
PUBLICATION
01 Jun, 2026
NGT plant patenting: betwixt and between regulatory continuity and expectations
The evolution of the concept of genetically modified organisms in the European Union in light of new genomic techniques (NGTs) is examined, along with the regulatory response that introduces a distinction between two categories of NGT plants, making the regime more flexible for those that can be considered equivalent to conventional plants. It also highlights that the institutional agreement reflected in the Council’s position represents a significant shift from the case law of the Court of Justice. Regarding patents, it highlights the absence of substantial changes, opting instead for a cautious approach based on transparency, monitoring, and possible future intervention.
01 Jun, 2026
PUBLICATION
28 May, 2026
Voluntary takeover bids and squeeze-outs
The Judgment of the Court of Justice of the European Union (Fifth Chamber) of 13 May 2026 (Korfin and Sempiola v Slovnaft, Case C-225/25) clarifies the concept of a takeover bid for the purposes of Article 2 of the 2004 Takeover Bids Directive, such that an offer made to the holders of securities of a company with a view to acquiring all or some of those securities does not fall within the concept of a takeover bid where it is made by an offeror who already controls the offeree company. Consequently, based on that court’s interpretation of the Directive’s provisions, there is no right of squeeze-out in such voluntary takeover bids.
28 May, 2026
PUBLICATION
27 May, 2026
An action for declaration of invalidity of an already-terminated franchise agreement is admissible
An action for declaration of invalidity of an agreement can almost always be brought, even if the agreement has been performed and terminated.
27 May, 2026